пятница, 28 октября 2011 г.

Use Of Common, But Potentially Dangerous, Pain Medicines Underreported

›
Patients underreported their use of common but potentially dangerous over-the-counter pain medications known as NSAIDs, according to researc...
вторник, 25 октября 2011 г.

GNS Healthcare And Biogen Idec Identify Novel, Patient-Specific Drug Targets For Rheumatoid Arthritis

›
GNS Healthcare, Inc., (GNS) the leading healthcare analytics company focused on enabling personalized medicine to improve human health, anno...
суббота, 22 октября 2011 г.

Molecular Response Of Cartilage To Injury Identified By Study

›
It's an unfortunate fact backed by studies of former professional football and soccer players: injury to joint cartilage escalates the r...
среда, 19 октября 2011 г.

The International Osteoporosis Foundation Joins ECCEO9 At Leading International Meeting In Athens

›
Collaboration results in enhanced scientific meeting, greater global perspective The International Osteoporosis Foundation (IOF) invites cli...
воскресенье, 16 октября 2011 г.

Humira(R) (adalimumab) Receives FDA Approval For Treatment Of Ankylosing Spondylitis

›
Abbott announced that the U.S. Food and Drug Administration (FDA) approved HUMIRA(R) (adalimumab) for reducing signs and symptoms in patient...
четверг, 13 октября 2011 г.

Arthritis Foundation And Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign

›
The Arthritis Foundation and Takeda Pharmaceuticals North America, Inc. announced the launch of a new educational campaign, Gout Living, to ...
понедельник, 10 октября 2011 г.

NICE Recommends Treatments For Rheumatoid Arthritis After The Failure Of A TNF Inhibitor

›
In draft final guidance published today, (25 June 2010) NICE recommends rituximab, adalimumab, etanercept, infliximab and abatacept, in cert...